The meetings...brought together ADAP representatives from California, Florida, Maryland, Massachusetts, New Jersey, New York, North Carolina and Texas...with representatives from Roche, GlaxoSmithKline, Merck, Pfizer, Abbott Laboratories, Boehringer-Ingelheim, Gilead Sciences and Bristol-Myers Squibb...Roche was the only company to come to a "satisfactory agreement" with the ADAPs...Five other drug companies have decided to continue negotiations, which are expected to conclude by late next month.